Validation of the Chinese version of EORTC QLQ ‐BN20 for patients with brain cancer

In conclusion, the Chinese version of EORTC QLQ BN20 questionnaire had great relevance, reliability, convergent validity and discriminant validity. It provides a valuable tool for the assessment of health‐related quality of life in clinical studies of Chinese patients with primary or secondary brain cancer.

Source: European Journal of Cancer Care - January 1, 2018 Category: Cancer & Oncology Authors: K. Zhang, J. Tian, Z. He, W. Sun, B. Pekbay, Y. Lin, D. Wu, J. Zhang, P. Chen, H. Guo, Y. Wan, M. Wang, S. Yang, J. Zheng, L. Zhang Tags: ORIGINAL ARTICLE Source Type: research